Immune reconstitution inflammatory syndrome (IRIS): Case series and review of the literature
- PMID: 40276120
- PMCID: PMC12019413
- DOI: 10.1016/j.rmcr.2025.102213
Immune reconstitution inflammatory syndrome (IRIS): Case series and review of the literature
Abstract
Background: Immune-reconstitution inflammatory syndrome (IRIS) is a dysregulated host inflammatory response following the initiation of appropriate therapy targeting an infectious disease. It is most commonly reported in human immunodeficiency virus patients following the initiation of antiretroviral therapy; however, IRIS can also be seen in immunocompromised patients without HIV, when the immune system is recovering. The diagnosis is confirmed using clinical and laboratory data after excluding differential diagnoses and concomitant infections.
Case series: Here, we describe three cases of patients with IRIS that were treated at our tertiary care center. The first case involves a paradoxical IRIS in an HIV-positive patient with TB, where the re-initiation of ART led to an inflammatory response despite effective anti-tuberculous treatment (ATT). The second case highlights unmasking IRIS in an HIV-positive patient, where the initiation of ART revealed an underlying Epstein-Barr virus (EBV)-associated B-cell lymphoma. The third case describes paradoxical worsening of pulmonary TB in an HIV-negative patient, expanding the scope of IRIS beyond its conventional association with HIV infection.
Conclusion: These cases illustrate the various manifestations of IRIS and emphasize the need for timely diagnosis and appropriate management strategies to mitigate the potentially severe outcomes associated with this syndrome. Our report highlights the challenges faced in the diagnosis of IRIS which impede prompt onset of therapy.
Keywords: HIV; IRIS; Immune reconstitution inflammatory syndrome; Lymphoma; TB; Tuberculosis.
© 2025 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Shelburne S.A., Hamill R.J., Rodriguez-Barradas M.C., Greenberg S.B., Atmar R.L., Musher D.W., et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine. 2002;81:213–227. doi: 10.1097/00005792-200205000-00005. - DOI - PubMed
-
- Cadena J., Thompson G.R., Ho T.T., Medina E., Hughes D.W., Patterson T.F. Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. Diagn. Microbiol. Infect. Dis. 2009;64(3):327–330. doi: 10.1016/j.diagmicrobio.2009.03.019. - DOI - PubMed
-
- Sun H.Y., Alexander B.D., Huprikar S., Forrest G.N., Bruno D., Lyon G.M., et al. Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression. Clin. Infect. Dis. 2015;60(1):36–44. doi: 10.1093/cid/ciu711. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
